期刊文献+

痛风降尿酸治疗依从性影响因素的研究进展 被引量:15

Advances in Research on Factors Influencing Adherence to Urate-lowering Therapy in Patients with Gout
下载PDF
导出
摘要 痛风发作期间,79%的患者会因疼痛及住院治疗无法正常工作,严重影响患者的工作和生活质量,其长期治疗目标是降低血尿酸水平,减少急性发作,改善患者预后。痛风患者血尿酸达标率低,与其降尿酸治疗依从性不佳有关。本文将痛风患者治疗依从性的影响因素,分为社会人口学因素、患者因素、医疗团队因素、疾病相关因素及治疗相关因素5个方面进行了总结,并指出提高其服药依从性的可能的干预措施。 Gout has a direct impact on the quality of work and daily lives.79% of the patients can not work due to pain and hospitalization during gout flares.The goal of long-term therapy is to lower the serum urate level to reduce recurrent acute gout flares and improve prognosis of patients.Researches have demonstrated that low serum urate control rate is associated with poor adherence to urate-lowering therapy.This article reviews 5 factors that influence adherence to urate-lowering therapy in patients with gout,including sociodemographic,patient-related,healthcare team-related,condition-related and therapy-related,and discusses potential interventions to improve the adherence to urate-lowering therapy.
作者 李博涵 方卫纲 沙悦 LI Bohan;FANG Weigang;SHA Yue(Department of General Practice,Chinese Academy of Medical Sciences&Peking Union Medical College,Division of General Internal Medicine,Peking Union Medical College Hospital,Beijing 100730,China;Department of Internal Medicine,Jiahui International Hospital,Shanghai 200030,China;Division of General Internal Medicine,Peking Union Medical College Hospital,Beijing 100730,China)
出处 《中国全科医学》 CAS 北大核心 2019年第7期865-869,共5页 Chinese General Practice
基金 公益性行业科研专项项目(201502024)
关键词 痛风 高尿酸血症 服药依从性 影响因素分析 综述 Gout Hyperuricemia Medication adherence Root cause analysis Review
  • 相关文献

参考文献6

二级参考文献59

  • 1关宝生,白雪,王艳秋,尹相林,李若男,周宪君,徐辉,杜文彦,邱洪斌.痛风/高尿酸血症患者生活习惯的危险因素[J].中国老年学杂志,2014,34(2):455-457. 被引量:60
  • 2周达生,姚华庭.医学系统工程与遵医行为研究[J].中国医院管理,1995,15(2):37-39. 被引量:583
  • 3Grassi D, Ferri L, Desideri G, et al. Chronic hyperuricemia, uric acid deposit and cardiovascular risk[J]. Curr Pharm Des, 2013, 19(13) : 2432-2438.
  • 4Smith EU, Diaz-Torn~ C, Perez-Ruiz F, et al. Epidemiology of gout: an update[J]. Best Pract Res Clin Rheumatol, 2010, 24 (6): 811-827.
  • 5Piret SE, Danoy P, Dahan K, et al. Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome 2p22.1- p21[J]. Hum Genet, 2011, 129(1): 51-58.
  • 6Vyletal P, Bleyer AJ, Kmoch S. Uromodulin biology and pathophysiology-an update[J]. Kidney Blood Press Res, 2010, 33(6): 456-475.
  • 7Zivna M, Hulkova H, Matignon M, et al. Dominant renin gene mutations associated with early-onset hyperurieemia, anemia, and chronic kidney failure[J]. Am J Hum Genet, 2009, 85(2):.204-213.
  • 8Bingham C, Ellard S, van't Hoff WG, et al. Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor- lbeta gene mutation[J]. Kidney Int, 2003, 63 (5) : 1645-1651.
  • 9Sampat R, Fu R, Larovere LE, et al. Mechanisms for phenotypic variation in Lesch-Nyhan disease and its variants[J]. Hum Genet, 2~Jll, 129(1): 71-78.
  • 10Moran R, Kuilenburg AB, Duley J, et al. Phosphoribosylpy- rophosphate synthetase superactivity and recurrent infections is caused by a p.Val142Leu mutation in PRS-I [J]. Am J Med Genet A, 2012, 158A(2): 455-460.

共引文献82

同被引文献148

引证文献15

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部